{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:56:27Z","timestamp":1761238587260,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471534","81601384"],"award-info":[{"award-number":["81471534","81601384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501407"],"award-info":[{"award-number":["81501407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Science and Technology Bureau","doi-asserted-by":"publisher","award":["3502Z20164003","2015-2-41"],"award-info":[{"award-number":["3502Z20164003","2015-2-41"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.intimp.2018.12.054","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T05:33:49Z","timestamp":1547530429000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Role of Galphaq in pathogenesis of psoriasis, a new mechanism about the immune regulation in psoriasis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-8194","authenticated-orcid":false,"given":"Hongyan","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangqian","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Huan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-3394","authenticated-orcid":false,"given":"Guixiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2018.12.054_bb0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2018.12.054_bb0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1684\/ejd.2012.1802","article-title":"Prevalence of psoriasis in China: a population-based study in six cities","volume":"22","author":"Ding","year":"2012","journal-title":"Eur. J. Dermatol."},{"issue":"28","key":"10.1016\/j.intimp.2018.12.054_bb0015","doi-asserted-by":"crossref","first-page":"46381","DOI":"10.18632\/oncotarget.18453","article-title":"Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2018.12.054_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2018.12.054_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0001-7310(09)73372-1","article-title":"Progress in understanding the immunopathogenesis of psoriasis","volume":"100","author":"Mak","year":"2009","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.intimp.2018.12.054_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2017.06.002","article-title":"TCR(+)CD3(+)CD4(\u2212)CD8(\u2212) effector T cells in psoriasis","volume":"181","author":"Brandt","year":"2017","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2018.12.054_bb0035","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.4049\/jimmunol.0902464","article-title":"Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis","volume":"184","author":"Guilloteau","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.054_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00063030-200519010-00006","article-title":"TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis","volume":"19","author":"Tobin","year":"2005","journal-title":"BioDrugs"},{"issue":"22","key":"10.1016\/j.intimp.2018.12.054_bb0045","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1073\/pnas.88.22.10049","article-title":"Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines","volume":"88","author":"Wilkie","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2018.12.054_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00005-013-0230-5","article-title":"The regulating function of heterotrimeric G proteins in the immune system","volume":"61","author":"Wang","year":"2013","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"8","key":"10.1016\/j.intimp.2018.12.054_bb0055","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20092735","article-title":"G alpha q-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity","volume":"207","author":"Misra","year":"2010","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.intimp.2018.12.054_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/icb.2014.53","article-title":"The deficiency of Galphaq leads to enhanced T-cell survival","volume":"92","author":"Wang","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2018.12.054_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3969023","article-title":"Gq-coupled receptors in autoimmunity","volume":"2016","author":"Zhang","year":"2016","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.intimp.2018.12.054_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-3083.2011.02635.x","article-title":"Expression of G protein alphaq subunit is decreased in lymphocytes from patients with rheumatoid arthritis and is correlated with disease activity","volume":"75","author":"Wang","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2018.12.054_bb0075","doi-asserted-by":"crossref","first-page":"4639081","DOI":"10.1155\/2017\/4639081","article-title":"Galphaq regulates the development of rheumatoid arthritis by modulating Th1 differentiation","volume":"2017","author":"Wang","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.intimp.2018.12.054_bb0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/icb.2015.13","article-title":"Galphaq controls rheumatoid arthritis via regulation of Th17 differentiation","volume":"93","author":"Liu","year":"2015","journal-title":"Immunol. Cell Biol."},{"issue":"25","key":"10.1016\/j.intimp.2018.12.054_bb0085","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.1073\/pnas.94.25.14089","article-title":"Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking Galphaq","volume":"94","author":"Offermanns","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.intimp.2018.12.054_bb0090","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.12.054_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2016.03.004","article-title":"CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages","volume":"82","author":"Morimura","year":"2016","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2018.12.054_bb0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/exd.13149","article-title":"Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes","volume":"26","author":"Stjernholm","year":"2017","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2018.12.054_bb0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2018.12.054_bb0110","first-page":"15280","article-title":"Characterization of the abnormal lipid profile in Chinese patients with psoriasis","volume":"8","author":"Pang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.intimp.2018.12.054_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/srep19295","article-title":"Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis","volume":"6","author":"Varshney","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2018.12.054_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2014.03.001","article-title":"Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases","volume":"88","author":"Ulivieri","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.intimp.2018.12.054_bb0125","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.4049\/jimmunol.0802672","article-title":"A major lipid raft protein raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses","volume":"182","author":"Saeki","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2018.12.054_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2018.12.054_bb0135","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2018.12.054_bb0140","first-page":"3188","article-title":"Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2018.12.054_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/467541","article-title":"Serum levels of TNF-alpha, IL-12\/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity","volume":"2014","author":"Kyriakou","year":"2014","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.intimp.2018.12.054_bb0150","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archderm.137.10.1373","article-title":"Cytokines may favor a role for human papillomaviruses in the pathogenesis of psoriasis","volume":"137","author":"Majewski","year":"2001","journal-title":"Arch. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2018.12.054_bb0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.bor.0000129715.35024.50","article-title":"Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis","volume":"16","author":"Chamian","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2018.12.054_bb0160","first-page":"0","article-title":"Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis","author":"Jeon","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.intimp.2018.12.054_bb0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/138920101506140910150227","article-title":"Progress of biological agents on psoriatic arthritis","volume":"15","author":"Li","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.054_bb0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000186689","article-title":"Functions and regulatory mechanisms of Gq-signaling pathways","volume":"17","author":"Mizuno","year":"2009","journal-title":"Neurosignals"},{"key":"10.1016\/j.intimp.2018.12.054_bb0175","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.intimp.2018.11.031","article-title":"ERK inhibitor JSI287 alleviates imiquimod-induced mice skin lesions by ERK\/IL-17 signaling pathway","volume":"66","author":"Huang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.12.054_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/569751","article-title":"The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis","volume":"2013","author":"Mavropoulos","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2018.12.054_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.2012.10939.x","article-title":"Inhibition of p38 kinase suppresses the development of psoriasis-like lesions in a human skin transplant model of psoriasis","volume":"167","author":"Mihara","year":"2012","journal-title":"Br. J. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918314401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918314401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T13:42:14Z","timestamp":1606052534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918314401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"alternative-id":["S1567576918314401"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.054","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Galphaq in pathogenesis of psoriasis, a new mechanism about the immune regulation in psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}